Purchase by BROADWOOD PARTNERS, L.P. / BROADWOOD CAPITAL INC / Neal C Bradsher
182,861 shares · @ $3.57 · $652,876
Insight Molecular Diagnostics Inc. Common Stock · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $6.16
+22% in 7d after detection
Post-detection moves
1h
—
1d
+2.1%
3d
+1.9%
7d
+22%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS